SCHEMBL22097133

SCHEMBL22097133

c1ccc(-c2cc(-c3ccc(-c4ccncc4)cc3)nc(-c3ccc4c(c3)c3ccccc3c3ccc5c6ccccc6n(-c6ccccc6)c5c34)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
DHODH Q02127 1/20 0.37
HSP90AA1 P07900 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 1/20 0.37
CYP19A1 P11511 1/20 0.36
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
IMPDH2 P12268 1/20 0.34
MAPK1 P28482 1/20 0.33
LMNA P02545 1/20 0.33
RECQL P46063 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
GSK3B P49841 1/20 0.32
PIK3CA P42336 1/20 0.32
CDC7 O00311 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097118 0.91 MAPT (0.37) MAPTMEN1KMT2ADHODHHSP90AA1
SCHEMBL22097247 0.87 MAPT (0.37) MAPTMEN1KMT2ADHODHHSP90AA1
SCHEMBL22097012 0.87 MAPT (0.39) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22096967 0.87 MAPT (0.39) MAPTMEN1KMT2AHSP90AA1KDM4E
SCHEMBL22097107 0.87 MEN1 (0.40) MAPTMEN1KMT2ADHODHKDM4E
SCHEMBL22097192 0.87 MEN1 (0.40) MAPTMEN1KMT2ADHODHKDM4E
SCHEMBL22097057 0.85 KMT2A (0.40) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL22096971 0.85 KMT2A (0.40) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL18846870 0.85 DHODH (0.41) MAPTMEN1KMT2ADHODHHSP90AA1
SCHEMBL18846522 0.85 DHODH (0.41) MAPTMEN1KMT2ADHODHHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 MAPT 508/4885MEN1 1207/4885KMT2A 2500/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 MAPT 508/4885MEN1 1207/4885KMT2A 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.